Publication | Open Access
Serial minimal residual disease (MRD) monitoring during first-line FCR treatment for CLL may direct individualized therapeutic strategies
36
Citations
30
References
2018
Year
OncologyIndividualized Therapeutic StrategiesClinical TrialsPathologyMolecular DiagnosticsFirst-line Fcr TreatmentMedicineNovel Therapy
| Year | Citations | |
|---|---|---|
Page 1
Page 1